A Randomized Trial of GM-CSF in Patients With ALI/ARDS
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This study will test the hypothesis that administration of granulocyte-macrophage colony
stimulating factor (GM-CSF) to patients with acute lung injury/acute respiratory distress
syndrome (ALI/ARDS) will improve the clinical course and outcome by shortening the duration
of mechanical ventilation for these patients.
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan
Collaborators:
Emory University National Heart, Lung, and Blood Institute (NHLBI) University of Colorado, Denver